EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C4H12NO7P2.3H2O.Na |
| Net Charge | 0 |
| Average Mass | 325.123 |
| Monoisotopic Mass | 325.03036 |
| SMILES | NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.O.O.O.[Na+] |
| InChI | InChI=1S/C4H13NO7P2.Na.3H2O/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;;;;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);;3*1H2/q;+1;;;/p-1 |
| InChIKey | DCSBSVSZJRSITC-UHFFFAOYSA-M |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of dimethylallyltranstransferase (EC 2.5.1.1). |
| Application: | bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| alendronate sodium trihydrate (CHEBI:2566) has part alendronate(1-) (CHEBI:50647) |
| alendronate sodium trihydrate (CHEBI:2566) has role bone density conservation agent (CHEBI:50646) |
| alendronate sodium trihydrate (CHEBI:2566) has role EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor (CHEBI:50643) |
| alendronate sodium trihydrate (CHEBI:2566) is a hydrate (CHEBI:35505) |
| alendronate sodium trihydrate (CHEBI:2566) is a organic sodium salt (CHEBI:38700) |
| IUPAC Name |
|---|
| sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate trihydrate |
| Synonym | Source |
|---|---|
| Monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrate | ChemIDplus |
| Brand Names | Source |
|---|---|
| Adronat | DrugBank |
| Arendal | DrugBank |
| Alendros | DrugBank |
| Fosamax | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| D00939 | KEGG DRUG |
| DB00630 | DrugBank |
| Alendronic_acid | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:13434693 | Reaxys |
| CAS:121268-17-5 | ChemIDplus |
| Citations |
|---|